Simulated microgravity improves maturation of cardiomyocytes derived from human induced pluripotent stem cells

被引:0
|
作者
Parvin Forghani
Aysha Rashid
Lawrence C. Armand
David Wolfson
Rui Liu
Hee Cheol Cho
Joshua T. Maxwell
Hanjoong Jo
Khalid Salaita
Chunhui Xu
机构
[1] Emory University School of Medicine and Children’s Healthcare of Atlanta,Department of Pediatrics
[2] Emory University,Biomolecular Chemistry, Department of Chemistry
[3] Emory University and Georgia Institute of Technology,Wallace H. Coulter Department of Biomedical Engineering
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) possess tremendous potential for basic research and translational application. However, these cells structurally and functionally resemble fetal cardiomyocytes, which is a major limitation of these cells. Microgravity can significantly alter cell behavior and function. Here we investigated the effect of simulated microgravity on hiPSC-CM maturation. Following culture under simulated microgravity in a random positioning machine for 7 days, 3D hiPSC-CMs had increased mitochondrial content as detected by a mitochondrial protein and mitochondrial DNA to nuclear DNA ratio. The cells also had increased mitochondrial membrane potential. Consistently, simulated microgravity increased mitochondrial respiration in 3D hiPSC-CMs, as indicated by higher levels of maximal respiration and ATP content, suggesting improved metabolic maturation in simulated microgravity cultures compared with cultures under normal gravity. Cells from simulated microgravity cultures also had improved Ca2+ transient parameters, a functional characteristic of more mature cardiomyocytes. In addition, these cells had improved structural properties associated with more mature cardiomyocytes, including increased sarcomere length, z-disc length, nuclear diameter, and nuclear eccentricity. These findings indicate that microgravity enhances the maturation of hiPSC-CMs at the structural, metabolic, and functional levels.
引用
收藏
相关论文
共 50 条
  • [31] The effects of cardioactive drugs on cardiomyocytes derived from human induced pluripotent stem cells
    Yokoo, Noritaka
    Baba, Shiro
    Kaichi, Shinji
    Niwa, Akira
    Mima, Takahiro
    Doi, Hiraku
    Yamanaka, Shinya
    Nakahata, Tatsutoshi
    Heike, Toshio
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 387 (03) : 482 - 488
  • [32] Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells
    Sewanan, Lorenzo R.
    Campbell, Stuart G.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2020, 598 (14): : 2909 - 2922
  • [33] Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
    Li, Jiangtao
    Feng, Xin
    Wei, Xiang
    [J]. STEM CELL RESEARCH & THERAPY, 2022, 13 (01)
  • [34] Using omics tools to improve differentiation and maturation of cardiomyocytes derived from human pluripotent stem cells
    Correia, C.
    Koshkin, A.
    Duarte, P.
    Teixeira, A.
    Serra, M.
    Alves, P. M.
    [J]. HUMAN GENE THERAPY, 2016, 27 (11) : A30 - A30
  • [35] The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin
    Lewandowski, Jaroslaw
    Rozwadowska, Natalia
    Kolanowski, Tomasz J.
    Malcher, Agnieszka
    Zimna, Agnieszka
    Rugowska, Anna
    Fiedorowicz, Katarzyna
    Labedz, Wojciech
    Kubaszewski, Lukasz
    Chojnacka, Katarzyna
    Bednarek-Rajewska, Katarzyna
    Majewski, Przemyslaw
    Kurpisz, Maciej
    [J]. CELL TRANSPLANTATION, 2018, 27 (07) : 1047 - 1067
  • [36] Tri-iodo-L-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells
    Yang, Xiulan
    Rodriguez, Marita
    Pabon, Lil
    Fischer, Karin A.
    Reinecke, Hans
    Regnier, Michael
    Sniadecki, Nathan J.
    Ruohola-Baker, Hannele
    Murry, Charles E.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2014, 72 : 296 - 304
  • [37] Maturation of human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) on polycaprolactone and polyurethane nanofibrous mats
    Iwon, Zuzanna
    Krogulec, Ewelina
    Tarnowska, Inez
    Lopianiak, Iwona
    Wojasinski, Michal
    Dobrzyn, Agnieszka
    Jastrzebska, Elzbieta
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Adaptation of cardiomyogenesis to the generation and maturation of cardiomyocytes from human pluripotent stem cells
    Martyniak, Alicja
    Jez, Mateusz
    Dulak, Jozef
    Stepniewski, Jacek
    [J]. IUBMB LIFE, 2023, 75 (01) : 8 - 29
  • [39] Maturation of human pluripotent stem cell derived cardiomyocytes in vitro and in vivo
    Gomez-Garcia, M. Juliana
    Quesnel, Elya
    Al-attar, Rasha
    Laskary, Andrew R.
    Laflamme, Michael A.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2021, 118 : 163 - 171
  • [40] Cardiomyocytes derived from human pluripotent stem cells for drug screening
    Zeevi-Levin, Naama
    Itskovitz-Eldor, Joseph
    Binah, Ofer
    [J]. PHARMACOLOGY & THERAPEUTICS, 2012, 134 (02) : 180 - 188